Luteal Phase Commencing of Growth Hormone

Gulhane School of Medicine61 enrolled

Overview

Commencing of growth hormone in luteal phase when follicular cohort for the next cycle is being gathered may increase mature oocytes in poor responder

Study Type

OBSERVATIONAL

Enrollment

Conditions

Infertility

Interventions

Norditropin penDRUG

12 IU per day

Eligibility

Sex: FEMALEMin age: 20 YearsMax age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Poor responder Exclusion Criteria: * FSH \>20 IU

Locations (1)

Ren Tıp ART Center

Bursa, Turkey (Türkiye)

Outcomes

Primary Outcomes

mature oocyte number

Time frame: 2 years

Secondary Outcomes

pregnancy rate

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.